Preventing pediatric cardiomyopathy: a 2015 outlook.


Cardiomyopathies in children encompass a broad range of diseases, both genetic and acquired, which manifest as a primary cardiac disorder or as a cardiomyopathy secondary to systemic disease. The burden of this group of disorders is substantial, and growing on a global scale. The availability of disease altering treatments is limited, and therefore a… (More)
DOI: 10.1586/14779072.2016.1129899


Cite this paper

@article{Kantor2016PreventingPC, title={Preventing pediatric cardiomyopathy: a 2015 outlook.}, author={Paul Fraser Kantor and Jake A Kleinman and Thomas D Ryan and Ivan Wilmot and Warren A Zuckerman and Linda J. Addonizio and Melanie D Everitt and John Lynn Jefferies and Teresa Sze Mun Lee and Jeffrey Allen Towbin and James Dean Wilkinson and Steven E. Lipshultz}, journal={Expert review of cardiovascular therapy}, year={2016}, volume={14 3}, pages={321-39} }